The Role of Organized Labor in Combating the Hepatitis B and Aids Epidemics: The Fight for an Osha Bloodborne Pathogens Standard

1995 ◽  
Vol 25 (1) ◽  
pp. 129-152 ◽  
Author(s):  
William A. Muraskin

The United States is experiencing a hepatitis B epidemic that has until recently received relatively little public attention. Many groups of workers are at risk of infection, death, or chronic carriership because of workplace exposure to blood; those at risk include not only health care professionals but police, fire fighters, life guards, hospital-based laundry and cafeteria workers, park rangers, sanitation workers, etc. One of the most important victories against the hepatitis B pandemic in the United States occurred when the Occupational Safety and Health Administration issued a Bloodborne Pathogens Standard that required employers to protect 5½ million workers from infection by offering those at risk free hepatitis B vaccination, and forced employers to bear the costs of providing equipment (e.g., gloves, gowns, masks, puncture-proof containers) to maintain “universal precautions” for employees handling bodily fluids. While most people assume the new standard was primarily aimed at fighting the AIDS epidemic, it was actually based on the more significant risk posed by hepatitis B infection. The standard resulted not from leadership provided by the experts in the Public Health Service mandated to control infectious disease, but rather from pressure applied by labor unions—providing a clear example of the continued importance of unions for worker protection in our supposedly post-union era.

2007 ◽  
Vol 28 (7) ◽  
pp. 783-790 ◽  
Author(s):  
Edgar P. Simard ◽  
Jeremy T. Miller ◽  
Prethibha A. George ◽  
Annemarie Wasley ◽  
Miriam J. Alter ◽  
...  

Background.Hepatitis B virus (HBV) infection is a well recognized risk for healthcare workers (HCWs), and routine vaccination of HCWs has been recommended since 1982. By 1995, the level of vaccination coverage among HCWs was only 67%.Objective.To obtain an accurate estimate of hepatitis B vaccination coverage levels among HCWs and to describe the hospital characteristics and hepatitis B vaccination policies associated with various coverage levels.Design.Cross-sectional survey.Methods.A representative sample of 425 of 6,116 American Hospital Association member hospitals was selected to participate, using probability-proportional-to-size methods during 2002-2003. The data collected included information regarding each hospital's hepatitis B vaccination policies. Vaccination coverage levels were estimated from a systematic sample of 25 HCWs from each hospital whose medical records were reviewed for demographic and vaccination data. The main outcome measure was hepatitis B vaccination coverage levels.Results.Among at-risk HCWs, 75% had received 3 or more doses of the hepatitis B vaccine, corresponding to an estimated 2.5 million vaccinated hospital-based HCWs. The coverage level was 81% among staff physicians and nurses. Compared with nurses, coverage was significantly lower among phlebotomists (71.1%) and nurses' aides and/or other patient care staff (70.9%; P < .05). Hepatitis B vaccination coverage was highest among white HCWs (79.5%) and lowest among black HCWs (67.6%; P < .05). Compared with HCWs who worked in hospitals that required vaccination only of HCWs with identified risk for exposure to blood or other potentially infectious material, hepatitis B vaccination coverage was significantly lower among HCWs who worked in hospitals that required vaccination of HCWs without identified risk for exposure to blood or other potentially infectious material (76.6% vs 62.4%; P < .05).Conclusions.In the United States, an estimated 75% of HCWs have been vaccinated against hepatitis B. Important differences in coverage levels exist among various demographic groups. Hospitals need to identify methods to improve hepatitis B vaccination coverage levels and should consider developing targeted vaccination programs directed at unvaccinated, at-risk HCWs who have frequent or potential exposure to blood or other potentially infectious material.


2017 ◽  
Vol 168 (4) ◽  
pp. 245 ◽  
Author(s):  
John Weiser ◽  
Alejandro Perez ◽  
Heather Bradley ◽  
Hope King ◽  
R. Luke Shouse

2020 ◽  
Vol 39 (6) ◽  
pp. 363-368
Author(s):  
Jeanne Perino ◽  
Christine N. Adams

In the United States, pregnant women are screened for hepatitis B antigen because of the significant risk of perinatal vertical transmission of hepatitis to the fetus. It is important that the maternal hepatitis B antigen screen is documented in the medical record to ensure appropriate prophylaxis for the neonate. The purpose of this column is to discuss the pathophysiology of hepatitis B, as well as the screening process and prophylaxis for the neonate.


Vaccines ◽  
2013 ◽  
Vol 1 (2) ◽  
pp. 167-173 ◽  
Author(s):  
Robert Stewart ◽  
Jeanne Sheffield

Sign in / Sign up

Export Citation Format

Share Document